AI biotech Insilico Medicine goes for third attempt at Hong Kong IPOnews2025-05-09T09:15:26+00:00May 9th, 2025|Endpoints News|
AI-focused biotech insitro cuts 22% of staff, citing ‘tumultuous market’news2025-05-08T18:22:26+00:00May 8th, 2025|Endpoints News|
AI biotech Recursion cuts pipeline to ‘sharpen focus’news2025-05-05T15:17:46+00:00May 5th, 2025|Endpoints News|
AI biotech Iambic debuts next-gen model Enchant for drug R&Dnews2025-05-05T12:30:05+00:00May 5th, 2025|Endpoints News|
Pathos AI gets AstraZeneca funding as biotech plans to raise up to $400Mnews2025-05-02T14:55:42+00:00May 2nd, 2025|Endpoints News|
Future House debuts free AI agent for science platformnews2025-05-01T15:30:48+00:00May 1st, 2025|Endpoints News|
Exclusive: AI biotech Stately Bio raises $12M for cell imagingnews2025-05-01T11:00:08+00:00May 1st, 2025|Endpoints News|
Endpoints Slack interview: Arc Institute’s Patrick Hsu on AI bio, investingnews2025-04-30T15:05:26+00:00April 30th, 2025|Endpoints News|
Exclusive: Axiom raises $15M to build AI models for drug toxicitynews2025-04-28T11:00:01+00:00April 28th, 2025|Endpoints News|
BigHat inks Eli Lilly deal for AI antibody research, extends Series Bnews2025-04-17T11:00:01+00:00April 17th, 2025|Endpoints News|
